title: Engaging community businesses in human immunodeficiency virus prevention: a feasibility study.
abstract: OBJECTIVE
  To explore the feasibility of engaging community businesses in human immunodeficiency virus (HIV) prevention.
  
  
  METHODS
  Randomly selected business owners/managers were asked to display discreetly wrapped condoms and brochures, both of which were provided free-of-charge for 3 months. Assessments were conducted at baseline, mid-program, and post-program. Customer feedback was obtained through an online survey.
  
  
  METHODS
  Participants were selected from a San Diego, California neighborhood with a high rate of acquired immune deficiency syndrome.
  
  
  METHODS
  Fifty-one business owners/managers who represented 10 retail categories, and 52 customers.
  
  
  METHODS
  Participation rates, descriptive characteristics, number of condoms and brochures distributed, customer feedback, business owners'/managers' program satisfaction, and business owners'/managers' willingness to provide future support for HIV prevention were measured.
  
  
  METHODS
  Kruskal-Wallis, Mann-Whitney U, Fisher's exact, and McNemar's tests were used to analyze data.
  
  
  RESULTS
  The 20 business owners/managers (39%) who agreed to distribute condoms and brochures reported fewer years in business and more employees than those who agreed only to distribute brochures (20%) or who refused to participate (41%; p < .05). Bars were the easiest of ten retail categories to recruit. Businesses with more employees and customers distributed more condoms and brochures (p < .05). More than 90% of customers supported distributing condoms and brochures in businesses, and 96% of business owners/managers described their program experience as positive.
  
  
  CONCLUSIONS
  Businesses are willing to distribute condoms and brochures to prevent HIV. Policies to increase business participation in HIV prevention should be developed and tested.
authors.affiliation: Center for Behavioral Epidemiology and Community Health, Graduate School of Public Health, San Diego State University, San Diego, California, USA. lrovniak@hmc.psu.edu
authors.forename: Liza S
authors.initials: LS
authors.lastname: Rovniak
authors.forename: Melbourne F
authors.initials: MF
authors.lastname: Hovell
authors.forename: C Richard
authors.initials: CR
authors.lastname: Hofstetter
authors.forename: Elaine J
authors.initials: EJ
authors.lastname: Blumberg
authors.forename: Carol L
authors.initials: CL
authors.lastname: Sipan
authors.forename: Marcia F
authors.initials: MF
authors.lastname: Batista
authors.forename: Ana P
authors.initials: AP
authors.lastname: Martinez-Donate
authors.forename: Mary M
authors.initials: MM
authors.lastname: Mulvihill
authors.forename: Guadalupe X
authors.initials: GX
authors.lastname: Ayala
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D000328:Adult; D000368:Aged; D003132:Commerce; D017280:Condoms / Q000706:statistics & numerical data; D003627:Data Interpretation, Statistical; D004777:Environment; D005240:Feasibility Studies; D005260:Female; D006678:HIV; D015658:HIV Infections / Q000517:prevention & control*; D018451:Homosexuality, Male; D006801:Humans; D008297:Male; D008875:Middle Aged; D015397:Program Evaluation; D012106:Research; D012111:Residence Characteristics; D021841:Safe Sex; D012931:Social Environment; D018709:Statistics, Nonparametric
references.citation: MMWR Morb Mortal Wkly Rep. 1993 Feb 12;42(5):95, 101
references.pmid: 8429815
references.citation: Vaccine. 2005 Feb 10;23(12):1437-45
references.pmid: 15670878
references.citation: Am J Public Health. 1999 Feb;89(2):204-8
references.pmid: 9949750
references.citation: Am J Public Health. 1999 Apr;89(4):567-8
references.pmid: 10191804
references.citation: J Appl Behav Anal. 1990 Summer;23(2):215-7
references.pmid: 2373657
references.citation: Am J Manag Care. 2007 Sep;13(9):524-8
references.pmid: 17803366
references.citation: Am J Public Health. 1988 Mar;78(3):287-90
references.pmid: 3341499
references.citation: Lancet. 1997 Nov 22;350(9090):1500-5
references.pmid: 9388397
references.citation: Natl Health Stat Report. 2008 Aug 6;(3):1-39
references.pmid: 18972720
references.citation: JAMA. 2008 Aug 6;300(5):520-9
references.pmid: 18677024
references.citation: Am J Public Health. 1999 Mar;89(3):336-45
references.pmid: 10076482